StockData
Pharming Group N.V. logo

Pharming Group N.V. (PHAR) stock

PHARNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Apr 2, 2026Score 8/30
$12.06−0.53 (-4.21%)

Close on Nov 17, 2026Market cap $846.23MP/E 301.5Yield –

Pharming revenue

Revenue is the money a company takes in from selling its products and services, before any costs are deducted.

For fiscal 2025 it was $376.13M, up 26.6% from the year before. The highest annual figure on record is $376.13M in fiscal 2025.

Annual revenue

PeriodPeriod endValueChange
FY2025Dec 31, 2025$376.13M+26.6%
FY2024Dec 31, 2024$297.20M+21.1%
FY2023Dec 31, 2023$245.32M+19.3%
FY2022Dec 31, 2022$205.62M+3.4%
FY2021Dec 31, 2021$198.87M-6.3%
FY2020Dec 31, 2020$212.17M+12.0%
FY2019Dec 31, 2019$189.39M–

More Pharming figures

See a number that looks wrong?